Rates and predictors for sustained ventricular tachycardia in patients with cardiac sarcoidosis and AV block as first cardiac presentation: Implications for device implantation
Patients with CS presenting with AVB have a high risk of sustained VA. Although immunosuppressive drugs may reduce the occurrence of VA, ICD implantation is reasonable, especially in case of RV LGE.
Authors
- Ingo Paetsch (ORCID: https://orcid.org/0000-0002-3528-7174)
- Hans Ebbinghaus
- Samuel Tobias Sossalla (ORCID: https://orcid.org/0000-0001-8034-2673)
- Laura Ueberham (ORCID: https://orcid.org/0000-0002-6645-3155)
- Cosima Jahnke (ORCID: https://orcid.org/0000-0001-9145-3467)
- Konrad Latuscynski
- Ulrich Laufs (ORCID: https://orcid.org/0000-0003-2620-9323)
- Borislav Dinov (ORCID: https://orcid.org/0000-0003-1104-8491)
- Carsten Henfling
Institutions
- University Hospital Leipzig (DE)
Publication Details
- Journal
- Heart Rhythm
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1016/j.hrthm.2024.09.020
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00